176 related articles for article (PubMed ID: 22342644)
21. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
22. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Seiwert TY; Jagadeeswaran R; Faoro L; Janamanchi V; Nallasura V; El Dinali M; Yala S; Kanteti R; Cohen EE; Lingen MW; Martin L; Krishnaswamy S; Klein-Szanto A; Christensen JG; Vokes EE; Salgia R
Cancer Res; 2009 Apr; 69(7):3021-31. PubMed ID: 19318576
[TBL] [Abstract][Full Text] [Related]
23. SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC).
Panchal O; Wichmann G; Grenman R; Eckhardt L; Kunz-Schughart LA; Franke H; Dietz A; Aigner A
Sci Rep; 2020 May; 10(1):8615. PubMed ID: 32451408
[TBL] [Abstract][Full Text] [Related]
24. An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome‑protamine-DNA-siRNA complex with cell permeable peptides.
Wang X; Wang X; Sun J; Fu S
Int J Mol Med; 2018 Nov; 42(5):2393-2402. PubMed ID: 30106091
[TBL] [Abstract][Full Text] [Related]
25. RETRACTED: Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer.
Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 Aug; 136(2):261-9. PubMed ID: 15300189
[TBL] [Abstract][Full Text] [Related]
26. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.
Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ
Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466
[TBL] [Abstract][Full Text] [Related]
27. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
28. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
[TBL] [Abstract][Full Text] [Related]
29. The promoted delivery of RRM2 siRNA to vascular smooth muscle cells through liposome-polycation-DNA complex conjugated with cell penetrating peptides.
Wu Y; Sun J; Li A; Chen D
Biomed Pharmacother; 2018 Jul; 103():982-988. PubMed ID: 29710515
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
Han J; Hu J; Sun F; Bian H; Tang B; Fang X
Mol Cell Biochem; 2021 Feb; 476(2):689-698. PubMed ID: 33125611
[TBL] [Abstract][Full Text] [Related]
31. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer.
Martens-de Kemp SR; Nagel R; Stigter-van Walsum M; van der Meulen IH; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
Clin Cancer Res; 2013 Apr; 19(8):1994-2003. PubMed ID: 23444224
[TBL] [Abstract][Full Text] [Related]
32. [Effect of cinobufotalin on growth of xenograft of endometrial carcinoma cell line ishikawa in nude mouse and its impact on RRM2 expression].
Feng K; Zhou HJ; Hu YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Nov; 30(11):1183-5. PubMed ID: 21275172
[TBL] [Abstract][Full Text] [Related]
33. Suppression of RRM2 inhibits cell proliferation, causes cell cycle arrest and promotes the apoptosis of human neuroblastoma cells and in human neuroblastoma RRM2 is suppressed following chemotherapy.
Li J; Pang J; Liu Y; Zhang J; Zhang C; Shen G; Song L
Oncol Rep; 2018 Jul; 40(1):355-360. PubMed ID: 29749541
[TBL] [Abstract][Full Text] [Related]
34. siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
Zuckerman JE; Hsueh T; Koya RC; Davis ME; Ribas A
J Invest Dermatol; 2011 Feb; 131(2):453-60. PubMed ID: 20944646
[TBL] [Abstract][Full Text] [Related]
35. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
Tang Q; Wu L; Xu M; Yan D; Shao J; Yan S
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1368-1379. PubMed ID: 32763454
[TBL] [Abstract][Full Text] [Related]
36. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
[TBL] [Abstract][Full Text] [Related]
37. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2008 Mar; 99(4):975-85. PubMed ID: 17929316
[TBL] [Abstract][Full Text] [Related]
38. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
40. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
